... and speaking about being concerned that the institution of the established cancer fighting industry and the chemo approach might do anything it takes to keep EntreMed at pay, consider the following article written by a blogger who thinks he knows how Provenge and DNDN got nailed to the wall.
By the way, this is an intelligent and thought provoking read, and it will raise your concerns about how difficult it may be for EntreMed to get Panzem approved. I also wanted to say that when Folkman said that Panzem may work best in concert with other traditional medications, I think what he was really saying was that if you want to get the 2ME2 products approved, what you had better do is not threaten the industry.
Remember, it is all about money and jobs. No one will be able to cost effectively cure a disease or fight cancer in this country because the FDA is more about protecting the industry than overseeing a process that assures the best drugs are efficiently brought to market as quickly as humany possible. To win, you have to play the game. I think EntreMed has learned this lesson, and that's why we are seeing so many combination tests.